Transenterix Inc (NYSEAMERICAN:TRXC) was the recipient of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 9,857,271 shares, a growth of 16.2% from the October 13th total of 8,480,583 shares. Based on an average daily volume of 34,701,062 shares, the days-to-cover ratio is currently 0.3 days. Approximately 10.2% of the shares of the company are short sold.
In other Transenterix news, insider Todd Pope sold 600,000 shares of the stock in a transaction dated Wednesday, October 18th. The shares were sold at an average price of $3.68, for a total transaction of $2,208,000.00. Following the completion of the transaction, the insider now owns 462,644 shares in the company, valued at $1,702,529.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Shares of Transenterix (NYSEAMERICAN:TRXC) opened at $3.19 on Tuesday. Transenterix has a one year low of $0.45 and a one year high of $5.00.
A number of equities analysts have recently commented on TRXC shares. Ladenburg Thalmann Financial Services set a $5.00 price objective on shares of Transenterix and gave the company a “buy” rating in a research report on Friday, October 20th. Zacks Investment Research lowered shares of Transenterix from a “buy” rating to a “sell” rating in a research report on Tuesday, August 8th. Finally, Stifel Nicolaus restated a “buy” rating and issued a $4.00 price objective (up from $3.75) on shares of Transenterix in a research report on Monday, October 30th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and two have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $2.61.
TRADEMARK VIOLATION WARNING: This piece of content was first published by TrueBlueTribune and is owned by of TrueBlueTribune. If you are viewing this piece of content on another site, it was stolen and reposted in violation of US and international copyright law. The original version of this piece of content can be viewed at https://www.truebluetribune.com/2017/11/14/transenterix-inc-trxc-short-interest-update.html.
TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.
Receive News & Ratings for Transenterix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix Inc and related companies with MarketBeat.com's FREE daily email newsletter.